Magazine article from our research archive:
|
|
Analyzing genes in vivo.(EMERGING TECHNOLOGIES: industrial)
- Article from:
-
R & D
- Article date:
-
October 1, 2006
|
Copyright informationCOPYRIGHT 2006 Advantage Business Media. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Researchers at Mirus Bio Corp., Madison, Wisc., have developed a new method to analyze gene function in vivo. The technique utilizes hydrodynamic injection technology to efficiently introduce a small interfering RNA (siRNA) to the liver of animal models, resulting in the suppression of target gene activity. ...
Related newspaper, magazine, and journal articles:
|
AREA TECH COMPANIES ANNOUNCE DEALS, IDEAS.(BUSINESS)
Wisconsin State Journal (Madison, WI);
September 9, 2004 ;
455 words
......livery technique being pioneered by Mirus Bio Corp., the Madison company reported...Russell Smestad, president of Mirus Bio Corp. Mirus has devised an elegantly...confocal microscope, left, at Mirus Bio Corp. in Madison uses laser light to...
|
|
SWISS GIANT ROCHE ACQUIRES MADISON FIRM MIRUS FOR $125M.(BUSINESS)
The Capital Times (Madison, WI);
July 22, 2008 ;
201 words
......giant Roche has acquired Madison-based Mirus Bio Corp. for $125 million, the two companies announced Tuesday. Mirus Bio is a leader in RNAi (ribonucleic acid...According to a press release from Mirus Bio, Roche will maintain the RNAi research...
|
|
CHRISTINE WOODDELL.(SAVVY)
The Capital Times (Madison, WI);
April 5, 2007 ;
446 words
......intrigued Christine Wooddell, a senior scientist at Mirus Bio Corp., 505 S. Rosa Road, a company whose proprietary delivery...CAPITAL TIMES Christine Wooddell, a senior scientist at Mirus Bio Corp., has flown to Paris to discuss with peers her company...
|
|
MIRUS BIO GETS GRANT FOR GENE THERAPY PRODUCT THE MADISON COMPANY IS...
Wisconsin State Journal (Madison, WI);
October 7, 2004 ;
267 words
...Byline: Judy Newman Wisconsin State Journal Mirus Bio Corp. of Madison has received a $1.26 million grant from the National Institutes of Health to develop a gene therapy product to treat...rather, the type that occurs in patients with kidney failure or AIDS or those undergoing chemotherapy for cancer ...
|
|
CALIFORNIA FIRM BUYING MADISON'S ALFALIGHT.(CAPITAL REGION BUSINESS...
Wisconsin State Journal (Madison, WI);
September 1, 2007 ;
674 words
......analytic and life sciences markets using nanotechnologies and liquid crystals. MIRUS BIO CORP SCIENTISTS FIND WAY TO BLOCK BAD PROTEINS Researchers at Mirus Bio Corp . in Madison have developed a technique to target specific cells with a genetic...
|
|
Mirus Bio Announces New RNAi Tool to Analyze Gene Function.
PR Newswire;
September 22, 2006 ;
592 words
...MADISON, Wis., Sept. 22 /PRNewswire/ -- Mirus Bio Corporation announced the development...Dr. Peter S. Linsley and the group at Mirus Bio led by Dr. David L. Lewis. The team utilized...mice. The new technique developed at Mirus Bio bypasses these hurdles and enables any...
|
|
Mirus Bio Announces Efficient New Genetic Immunization Method to Produce...
PR Newswire;
March 15, 2006 ;
489 words
......March 15 /PRNewswire/ -- Scientists at Mirus Bio Corporation have developed a genetic...hurdles. The new technique developed at Mirus Bio bypasses these hurdles and enables research...portfolio, notes Jon A. Wolff, M.D., Mirus Bio's Chief Scientific Officer. This research...
|
|
Madison, Wis.-based gene therapy firm receives $1.26 million grant.
WI State Journal (Madison, WI);
October 7, 2004 ;
325 words
...Byline: Judy Newman Oct. 7--Mirus Bio Corp. of Madison has received a $1.26 million grant from the National Institutes of Health to develop a gene therapy product to treat...rather, the type that occurs in patients with kidney failure or AIDS or those undergoing chemotherapy for cancer treatment, said ...
|
|
CRASH KILLS UW SCIENTIST.(METRO)
The Capital Times (Madison, WI);
December 10, 2005 ;
137 words
......Sunrise Ridge Trail in the town of Springfield. Along with his work at the Waisman Center Budker was a co-founder of the Mirus Bio Corp., a gene therapy firm that has been exploring ways to combat such diseases as muscular dystrophy and anemia. Budker...
|
|
PATENTS.(BUSINESS)
Wisconsin State Journal (Madison, WI);
October 19, 2006 ;
468 words
......James E., Budker, Vladimir G. Middleton Assignee: Mirus Bio Corp., Madison Title: Polyampholytes for Delivering Polyions...James E., Trubetskoy, Vladimir, Middleton Assignee: Mirus Bio Corp., Madison Title: Ribonuclease Zymogen Design Patent...
|
|
Wisconsin Inventors Develop Labile Disulfide Bond Containing Compound
US Fed News Service, Including US State News;
August 9, 2006 ;
184 words
......Trademark Office announced. The inventors were issued U.S. Patent No. 7,087,770 on Aug. 8. The patent has been assigned to Mirus Bio Corp., Madison. The original application was filed on Feb. 8, 2001, and is available at: http://patft.uspto.gov/netacgi...
|
|
Mirus has deal with Pfizer.
WI State Journal (Madison, WI);
January 10, 2007 ;
329 words
......Madison biotechnology company has signed a multimillion-dollar agreement with the world's largest pharmaceutical company. Mirus Bio Corp., founded in 1996 by three UW-Madison researchers, has entered into a two-year deal with Pfizer to work on RNA interference...
|
|
Mirus Bio Awarded Broad European Patent Covering Intravascular Injection...
PR Newswire;
October 31, 2006 ;
427 words
...MADISON, Wis., Oct. 31 /PRNewswire/ -- Mirus Bio Corporation announced today the grant...produce the encoded therapeutic agent. Mirus Bio is applying this powerful tool to such...domestically, commented Russell Smestad, Mirus Bio's President. The lack of safe, clinically...
|
|
Mirus Bio Corporation Enters Into Agreement With Pfizer Inc. to Evaluate...
PR Newswire;
January 9, 2007 ;
613 words
...MADISON, Wis., Jan. 9 /PRNewswire/ -- Mirus Bio Corporation announced today it has entered...animal models. The studies will utilize Mirus Bio's nucleic acid delivery platforms to...interference, commented Russell Smestad, Mirus Bio's President. We are excited that this...
|
See all results.
Or, try our
Advanced Search.
|